featured
Risk of Hepatocellular Carcinoma Development in Patients With Treated Chronic Hepatitis B– Related Cirrhosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Five-Year Comparative Risk of Hepatocellular Carcinoma Development Under Entecavir or Tenofovir Treatment-Naïve Patients With Chronic Hepatitis B-Related Compensated Cirrhosis in Taiwan
Aliment. Pharmacol. Ther. 2020 Dec 01;52(11-12)1695-1706, TH Hu, S Yueh-Hsia Chiu, PL Tseng, CH Chen, SN Lu, JH Wang, CH Hung, KM Kee, MT Lin, KC Chang, MC Lin, RN ChienFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.